Recombinant antigen gp19 for Ehrlichia canis

Ehrlichia canis

gp19 is a major epitope of the bacteria Ehrlichia canis, which can be used for the detection of early acute-phase antibodies and reacts strongly with antibodies in late-acute-phase sera from experimental dogs. gp19 is encoded by a highly conserved single gene that minimizes or eliminates the potential for serologic variability.

Recombinant antigen for the diagnosis of Ehrlichiosis caused by Ehrlichia canis, a human and animal infectious disease (mainly dogs).

or
Name
gp19
Description
Glycoprotein
Gene
gp19
Purity
> 95% by observation on SDS-PAGE electrophoresis
Cat number
SKU Source Applications In-house validation Details
RAG0025 Top product (Satisfaction guarantee) E. coli WB, DB, IE, DE, CLIA, LF - Example of a certificate of analysis Material Safety Data Sheet
WB: Western Blot | DB: Dot Blot | IE: Indirect ELISA | DE: positive control in Direct ELISA | CLIA: Chemiluminescent immunoassay | LF: Lateral-Flow | CE: Capture ELISA | DAS: Double Antigen Sandwich ELISA | NP: Nanoparticles binding | PO: Plate orientation | COA: Certificate of analysis | SDS: Material Safety Data Sheet
Top product (Satisfaction guarantee) Top product (Satisfaction guarantee)
Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk
* under availability, for liquid format
Related antibodies

For research and comercial use IVD only (*)

(*) Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. You can get more information about the general features and about the shipping, storage, defrost, manipulation and stability of all of our reagents. In addition, we follow a rigorous quality control for each lot.

Bact to list of Recombinant antigens for infectious diseases

How to reconsitute lyophizated vials